Less than one quarter of pathology labs have adopted whole-slide imaging so far, but pathologists and companies in the space ...

Shares in the pathology company jumped 6 per cent after it achieved a robust price for Lumus, which does MRI, X-rays and CT ...

OnAsset's Director of Sales. OnAsset and Phaslo's joint solutions have been deployed for over 12 months and are now scaling to support the broader market. Early successes have proven the market fit, ...

ASX 200 investors appear uncertain about the healthcare stock’s divestment. But why? The post ASX 200 healthcare stock soars ...

Healius is set to become debt-free after selling its radiology business, Lumus Imaging, for $965 million, exceeding analyst ...

Healthcare services provider Healius has agreed to sell its Lumus Imaging subsidiary to funds managed by Asian private equity ...

While it’s a shame it got to the point that the company had to sell its radiology arm, and that it took so long to get there, ...

Healius will be in a “material net cash position’’ following the sale of its Lumus Imaging division for $965m, and will ...

Healius (ASX:HLS) is selling Lumus Imaging in a $965 million deal to pay down debt and ‘return cash to shareholders’. While ...

The sale represents a total consideration of $965 million with cash proceeds estimated to be around $835 million. The sale of Lumus which accounts for almost half of the fiscal 2024 group operating ...

Katharine Mitropoulos, an author and the founder of Set Sail Press LLC, hosted a book launch event for her second book, ...

GRM and HistoWiz expand their partnership, with HistoWiz now using GRM's pathology storage services for blocks and slides.